Buriolla, S.; Pelizzari, G.; Corvaja, C.; Alberti, M.; Targato, G.; Bortolot, M.; Torresan, S.; Cortiula, F.; Fasola, G.; Follador, A.
Immunotherapy in NSCLC Patients with Brain Metastases. Int. J. Mol. Sci. 2022, 23, 7068.
https://doi.org/10.3390/ijms23137068
AMA Style
Buriolla S, Pelizzari G, Corvaja C, Alberti M, Targato G, Bortolot M, Torresan S, Cortiula F, Fasola G, Follador A.
Immunotherapy in NSCLC Patients with Brain Metastases. International Journal of Molecular Sciences. 2022; 23(13):7068.
https://doi.org/10.3390/ijms23137068
Chicago/Turabian Style
Buriolla, Silvia, Giacomo Pelizzari, Carla Corvaja, Martina Alberti, Giada Targato, Martina Bortolot, Sara Torresan, Francesco Cortiula, Gianpiero Fasola, and Alessandro Follador.
2022. "Immunotherapy in NSCLC Patients with Brain Metastases" International Journal of Molecular Sciences 23, no. 13: 7068.
https://doi.org/10.3390/ijms23137068
APA Style
Buriolla, S., Pelizzari, G., Corvaja, C., Alberti, M., Targato, G., Bortolot, M., Torresan, S., Cortiula, F., Fasola, G., & Follador, A.
(2022). Immunotherapy in NSCLC Patients with Brain Metastases. International Journal of Molecular Sciences, 23(13), 7068.
https://doi.org/10.3390/ijms23137068